News
As global trade tensions and economic uncertainties continue to shape market sentiment, Asian markets are navigating these challenges with resilience, highlighted by strategic policy adjustments and ...
20h
The Chosun Ilbo on MSNS. Korean biopharma set to surpass 10 tn won in tech exports this yearSouth Korean pharmaceutical and biotech companies are on track to exceed 10 trillion won ($7.5 billion) in licensing revenues ...
13h
The Island Packet on MSNFor 400 million years, one local sea creature has been calling the coast home.Every spring horseshoe crabs come to South Carolina beaches to reproduce. A volunteer initiative with the SCDNR helps ...
19h
ET Now on MSN1st-ever stock split + dividend: NSE-listed pharma company's twin treat for shareholders - Record date fixedPharma company has announced a stock split in the ratio of 5:1. The purpose of the stock split as stated by the NSE-listed ...
Two great examples are Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) and Vertex Pharmaceuticals (NASDAQ: VRTX). Warren ...
Novartis is currently the world's No.1 pharma company. The report warns that big pharma companies can't rest on their laurels if they want to stay on top, with a host of new firms challenging ...
(Reuters) -The founder of 23andMe, Anne Wojcicki, has asked a U.S. judge to reopen an auction for the genetic testing company ...
Almac joined an elite group of NI businesses with an annual turnover of more than £1bn this week - but who are the others?
Here are the top business stories in Cyprus from the week starting May 26: Cyprus inaugurated its new Business Support Centre ...
Megarounds were up 50% over 2023, and 8 of the top 20 deals in regions we cover ... from crossover investors also suggests highly-valued companies are poised to capitalise on the expected global ...
Pharmaceutical manufacturer Sigachi Industries has announced a 10 per cent final dividend for FY25 after posting a strong Q4 ...
The Mumbai-based drug major said the capital outlay will help in significantly strengthening the company’s speciality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results